"Non-steroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease is also known as Samter syndrome (or triad), Widal syndrome, aspirin-induced asthma, aspirin exacerbated respiratory disease (AERD), and analgesic-induced asthma."
"Non-steroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease is also known as Samter syndrome (or triad), Widal syndrome, aspirin-induced asthma, aspirin exacerbated respiratory disease (AERD), and analgesic-induced asthma."
"Non-steroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease is also known as Samter syndrome (or triad), Widal syndrome, aspirin-induced asthma, aspirin exacerbated respiratory disease (AERD), and analgesic-induced asthma."
"Non-steroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease is also known as Samter syndrome (or triad), Widal syndrome, aspirin-induced asthma, aspirin exacerbated respiratory disease (AERD), and analgesic-induced asthma."
"Non-steroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease is also known as Samter syndrome (or triad), Widal syndrome, aspirin-induced asthma, aspirin exacerbated respiratory disease (AERD), and analgesic-induced asthma."
"Non-steroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease is also known as Samter syndrome (or triad), Widal syndrome, aspirin-induced asthma, aspirin exacerbated respiratory disease (AERD), and analgesic-induced asthma."
"In adults, prevalence ranges between 8-20% among those given an oral provocation test (OPT), and around 3-5% among patients who self-report that they have the triad 5."
"History and etymology"